Randall D. Seifert

624 total citations
32 papers, 465 citations indexed

About

Randall D. Seifert is a scholar working on Pharmacology, Geriatrics and Gerontology and Psychiatry and Mental health. According to data from OpenAlex, Randall D. Seifert has authored 32 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 9 papers in Geriatrics and Gerontology and 6 papers in Psychiatry and Mental health. Recurrent topics in Randall D. Seifert's work include Pharmaceutical Practices and Patient Outcomes (7 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Schizophrenia research and treatment (5 papers). Randall D. Seifert is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (7 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Schizophrenia research and treatment (5 papers). Randall D. Seifert collaborates with scholars based in United States and Germany. Randall D. Seifert's co-authors include Robert J. Cipolle, Darwin E. Zaske, E Haus, Barbara A. Neilan, Manuel Ramirez‐Lassepas, Keith A. Rodvold, Neal R. Cutler, Russell Gardner, John Jamieson and Piotr Sobieszczyk and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Biological Psychiatry.

In The Last Decade

Randall D. Seifert

30 papers receiving 421 citations

Peers

Randall D. Seifert

SURGE

IM

CCM

PHARM

HEMAT

Mary Loverde United States

Maja Hellfritzsch Denmark

Jeroen Diepstraten Netherlands

Jane Skov Denmark

Margaret L. Ackman Canada

Patrice Queneau France

Darrell Hulisz United States

Michael Ganetsky United States

Charles D. Ponte United States

Juan Cosín Spain

Mary Loverde United States

Randall D. Seifert

88 ×0.6

SURGE

84 ×0.7

IM

165 ×1.6

CCM

63 ×1.0

PHARM

82 ×1.4

HEMAT

Citations per year, relative to Randall D. Seifert Randall D. Seifert (= 1×) peers Mary Loverde

Countries citing papers authored by Randall D. Seifert

Since Specialization

Citations

This map shows the geographic impact of Randall D. Seifert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randall D. Seifert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randall D. Seifert more than expected).

Fields of papers citing papers by Randall D. Seifert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randall D. Seifert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randall D. Seifert. The network helps show where Randall D. Seifert may publish in the future.

Co-authorship network of co-authors of Randall D. Seifert

This figure shows the co-authorship network connecting the top 25 collaborators of Randall D. Seifert. A scholar is included among the top collaborators of Randall D. Seifert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randall D. Seifert. Randall D. Seifert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

King‐Kallimanis, Bellinda L., Vishal Bhatnagar, Bindu Kanapuru, et al.. (2023). Measuring Frailty Using Patient-Reported Outcomes (PRO) Data: A Feasibility Study in Patients with Multiple Myeloma. Quality of Life Research. 32(8). 2281–2292. 2 indexed citations

2.

King‐Kallimanis, Bellinda L., Vishal Bhatnagar, Bindu Kanapuru, et al.. (2023). Patient-reported frailty phenotype (PRFP) vs. International Myeloma Working Group frailty index (IMWG FI) proxy: A comparison between two approaches to measuring frailty. Journal of Geriatric Oncology. 15(2). 101681–101681. 4 indexed citations

3.

Brown, Jacob T., et al.. (2023). Addressing disparities in pharmacogenomics through rural and underserved workforce education. Frontiers in Genetics. 13. 1082985–1082985. 6 indexed citations

4.

Pittenger, Amy L., et al.. (2019). Innovative Partnership Between a Rural Mental Health Center and Community Pharmacy: Integration of a Mental Health Pharmacist. SHILAP Revista de lepidopterología. 10(2). 17–17. 3 indexed citations

5.

Gulseth, Michael P., Piotr Sobieszczyk, John Fanikos, & Randall D. Seifert. (2008). Applying Quality Measures and Guidelines in the Management of Acute Coronary Syndrome and Venous Thromboembolism. Journal of Managed Care Pharmacy. 14(6 Supp A). 1–30. 27 indexed citations

6.

Brown, Michael C., Michael Kotlyar, Jeannine M. Conway, Randall D. Seifert, & John V. St. Peter. (2007). Integration of an Internet-based Medical Chart Into a Pharmacotherapy Lecture Series. American Journal of Pharmaceutical Education. 71(3). 53–53. 3 indexed citations

7.

Brown, Michael C., Michael Kotlyar, Jeannine M. Conway, Randall D. Seifert, & John V. St. Peter. (2007). Integration of an Internet-based Medical Chart Into a Pharmacotherapy Lecture Series. American Journal of Pharmaceutical Education. 71(3). 53–53. 29 indexed citations

8.

Kees, Frieder, Michael Bucher, Frank Schweda, et al.. (2007). Neoimmun versus Neoral: a bioequivalence study in healthy volunteers and influence of a fat-rich meal on the bioavailability of Neoimmun. Naunyn-Schmiedeberg s Archives of Pharmacology. 375(6). 393–399. 16 indexed citations

9.

Cutler, Neal R., Randall D. Seifert, John J. Sramek, et al.. (1995). Acetylcholinesterase inhibition by zifrosilone: Pharmacokinetics and pharmacodynamics*. Clinical Pharmacology & Therapeutics. 58(1). 54–61. 21 indexed citations

10.

Cutler, N.R., et al.. (1994). Safety, tolerance, pharmacokinetic and RBC cholinesterase activity of MDL 73,745. Biological Psychiatry. 35(9). 680–680. 2 indexed citations

11.

Cutler, N.R., et al.. (1994). A bridging study of xanomeline tartrate in Alzheimer's disease (AD). Biological Psychiatry. 35(9). 628–628. 1 indexed citations

12.

Cutler, N.R., et al.. (1994). Maximally tolerated dose of the muscarinic agonist CI-979 in Alzheimer's disease (AD). Biological Psychiatry. 35(9). 628–628. 2 indexed citations

13.

Cutler, Neal R., et al.. (1993). The Use of the Computerized Neuropsychological Test Battery (CNTB) in an Efficacy and Safety Trial of BMY 21,502 in Alzheimer's Disease. Annals of the New York Academy of Sciences. 695(1). 332–336. 16 indexed citations

14.

Cutler, Neal R., et al.. (1993). Comparison of quantitative methodologies to define chronic pressure ulcer measurements.. PubMed. 6(6). 22–30. 28 indexed citations

15.

Seifert, Randall D.. (1989). Therapeutic Drug Monitoring: Psychotropic Drugs. Journal of Pharmacy Practice. 2(6). 403–415. 2 indexed citations

16.

Seifert, Randall D., John Jamieson, & Russell Gardner. (1983). Use of Anticholinergics in the Nursing Home: An Empirical Study and Review. Drug Intelligence & Clinical Pharmacy. 17(6). 470–473. 20 indexed citations

17.

Cipolle, Robert J., et al.. (1983). Heparin-associated thrombocytopenia: a prospective evaluation of 211 patients.. PubMed. 5(2). 205–11. 46 indexed citations

18.

Seifert, Randall D., et al.. (1982). Benzodiazepine utilization in a family medicine residency program.. PubMed. 15(3). 497–500. 2 indexed citations

19.

Cipolle, Robert J., Randall D. Seifert, Barbara A. Neilan, Darwin E. Zaske, & E Haus. (1981). Heparin kinetics: Variables related to disposition and dosage. Clinical Pharmacology & Therapeutics. 29(3). 387–393. 100 indexed citations

20.

Cipolle, Robert J., Randall D. Seifert, Darwin E. Zaske, & Richard G. Strate. (1980). Systematically Individualizing Tobramycin Dosage Regimens. The Journal of Clinical Pharmacology. 20(10). 570–580. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact